TheFiscalFinder
● Single award · contract

Advanced Development of Recombinant Protective Antigent (Rpa) Anthrax Vaccine Can 1990087

A single federal award, with both ends of the trail linked.
$93M
total award value
2010
action date
141 mo
period
HHSO100201000059C
PIID
Agency ›
Department of Health and Human Services
✓ from source
awarded→$93M
Recipient ›
Emergent Product Development Gaithersburg Inc.
✓ from source
performed in→
State ›
Maryland
✓ from source

Description

TAS::75 0140::TAS Advanced Development of Recombinant Protective Antigent (Rpa) Anthrax Vaccine Can 1990087

Awarding agencyDepartment of Health and Human Services →
RecipientEmergent Product Development Gaithersburg Inc. →
Place of performanceMaryland →
CategoryPSC C118NAICS 541711
Competed?Not recorded✓ from source
Total (exact)$92,988,270

More awards to Emergent Product Development Gaithersburg Inc.

Contract HHSO100201600030C
awarded 2016$1.4B
ACAM2000, Smallpox (Vaccinia) Vaccine, Live (Acam)
awarded 2019$857.6M
Medical Countermeasures (Mcm) That Can Be Deployed in the Event of a Filovirus…
awarded 2023$118.6M
All awards to this recipient →

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
Medicaid Entitlement for 7 - Fy 2022 Quarter 4 - T19
awarded 2022$71.7B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.